157 related articles for article (PubMed ID: 36880113)
21. Laparoscopic radiofrequency ablation of subcapsular hepatocellular carcinomas: risk factors related to a technical failure.
Ko SE; Lee MW; Min JH; Ahn SH; Rhim H; Kang TW; Song KD; Kim JM; Choi GS; Cha DI; Lim HK
Surg Endosc; 2022 Jan; 36(1):504-514. PubMed ID: 33523278
[TBL] [Abstract][Full Text] [Related]
22. Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization.
Gu JH; Zhao QY; He C; Ye ZD; Xu M; Jiang TA
Int J Hyperthermia; 2021; 38(1):1092-1098. PubMed ID: 34296656
[TBL] [Abstract][Full Text] [Related]
23. Hand-assisted laparoscopic ultrasound-guided radiofrequency thermal ablation of liver tumors: a technical report.
Machi J; Oishi AJ; Mossing AJ; Furumoto NL; Oishi RH
Surg Laparosc Endosc Percutan Tech; 2002 Jun; 12(3):160-4. PubMed ID: 12080255
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
[TBL] [Abstract][Full Text] [Related]
25. Bipolar radiofrequency ablation for liver tumors: comparison of contrast-enhanced ultrasound with contrast-enhanced MRI/CT in the posttreatment imaging evaluation.
Bo XW; Xu HX; Sun LP; Zheng SG; Guo LH; Lu F; Wu J; Xu XH
Int J Clin Exp Pathol; 2014; 7(9):6108-16. PubMed ID: 25337258
[TBL] [Abstract][Full Text] [Related]
26. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
Min JH; Lim HK; Lim S; Kang TW; Song KD; Choi SY; Rhim H; Lee MW
Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
[TBL] [Abstract][Full Text] [Related]
27. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
[No Abstract] [Full Text] [Related]
28. Comparison of computed tomography (CT) and contrast-enhanced ultrasound (CEUS) for the quantitative evaluation of an ablation defect following radiofrequency ablation of malignant liver lesions.
Bruenn K; Beyer L; Haimerl M; Pregler B; Stroszczynski C; Jung EM; Wiggermann P
Clin Hemorheol Microcirc; 2017; 67(3-4):445-451. PubMed ID: 28885212
[TBL] [Abstract][Full Text] [Related]
29. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
[TBL] [Abstract][Full Text] [Related]
30. Computer-Aided Color Parameter Imaging of Contrast-Enhanced Ultrasound Evaluates Hepatocellular Carcinoma Hemodynamic Features and Predicts Radiofrequency Ablation Outcome.
Wang H; Guo W; Yang W; Liu G; Cao K; Sun Y; Liang ZN; Bai XM; Wang S; Wu W; Yan K; Goldberg SN
Ultrasound Med Biol; 2022 Aug; 48(8):1555-1566. PubMed ID: 35597704
[TBL] [Abstract][Full Text] [Related]
31. Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.
Wiggermann P; Brünn K; Rennert J; Loss M; Wobser H; Schreyer AG; Stroszczynski C; Jung EM
Ultraschall Med; 2013 Dec; 34(6):590-4. PubMed ID: 24132649
[TBL] [Abstract][Full Text] [Related]
32. Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies.
da Silva NPB; Beyer LP; Hottenrott MC; Hackl C; Schlitt HJ; Stroszczynski C; Wiggermann P; Jung EM
Clin Hemorheol Microcirc; 2017; 66(4):357-368. PubMed ID: 28598835
[TBL] [Abstract][Full Text] [Related]
33. Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular carcinoma - A prospective randomized controlled trial.
Huang Q; Zeng Q; Long Y; Tan L; Zheng R; Xu E; Li K
Int J Hyperthermia; 2019; 36(1):1207-1215. PubMed ID: 31813295
[No Abstract] [Full Text] [Related]
34. Mid- to long-term outcome of laparoscopic ultrasound-guided radiofrequency ablation for malignant hepatic tumors.
Chern MC; Lin CW; Lin ZH; Tsai TJ
J Gastrointest Surg; 2024 Feb; 28(2):103-107. PubMed ID: 38445930
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic radiofrequency of hepatocellular carcinoma (HCC) in liver cirrhosis.
Montorsi M; Santambrogio R; Bianchi P; Opocher E; Tagliaferri B; Zuin M; Bertolini E; Podda M
Hepatogastroenterology; 2001; 48(37):41-5. PubMed ID: 11268995
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of enhancement rate by enhanced ultrasound in hepatitis B virus-positive hepatocellular carcinoma undergoing radiofrequency ablation.
Zhou G; Cai ZQ; Luo J; Hu ZX; Luo H; Wu H; Chen Q
Asia Pac J Clin Oncol; 2019 Aug; 15(4):238-243. PubMed ID: 31119840
[TBL] [Abstract][Full Text] [Related]
37. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
[TBL] [Abstract][Full Text] [Related]
38. [The occurrence and clinical significance of contrast agent spillover on immediate enhanced CT reexamination after radiofrequency ablation of liver cancer].
Gao QZ; Wang ZW; Pan J; Shi HF; Zhang XB; Jin ZY
Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):503-507. PubMed ID: 30317772
[No Abstract] [Full Text] [Related]
39. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
